Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1973 Oct;4(4):396-401.
doi: 10.1128/AAC.4.4.396.

Bactericidal activity and pharmacology of cefazolin

Clinical Trial

Bactericidal activity and pharmacology of cefazolin

M G Bergeron et al. Antimicrob Agents Chemother. 1973 Oct.

Abstract

The in vitro bactericidal activity of cefazolin was found to be similar to that of cephaloridine and cephalothin but slightly greater than that of cephalexin against a majority of 233 strains of gram-positive and gram-negative organisms. Cefazolin, however, was two- to eightfold more active than the other two drugs against Escherichia coli and klebsiella. The mean peak concentrations in the serum in 10 normal subjects 1 h after intramuscular injections of 1,000, 500, and 250 mg of cefazolin were 38.8, 18.6, and 12.2 mug/ml, respectively. The antibiotic could still be detected at 8 h. Peak values for a given dose of cephaloridine were comparable. However, blood levels of cefazolin were regularly higher than those of cephaloridine over the first 8 h. The mean half-life of cefazolin in the serum was 2 h, whereas that of cephaloridine was 1.4 h. The degree of serum protein-binding was strikingly higher for cefazolin (81%) than for cephaloridine (24%), suggesting that the antibacterial activity of the former in serum might be less than that of cephaloridine after equal doses. This proved to be the case when the bacterial activity of blood drawn 1, 4, and 8 h after injection of the two drugs was examined.

PubMed Disclaimer

References

    1. Antimicrob Agents Chemother (Bethesda). 1965;5:1025-34 - PubMed
    1. J Antibiot (Tokyo). 1970 Apr;23(4):184-94 - PubMed
    1. J Antibiot (Tokyo). 1970 Mar;23(3):131-6 - PubMed
    1. J Antibiot (Tokyo). 1970 Mar;23(3):137-48 - PubMed
    1. Antimicrob Agents Chemother (Bethesda). 1969;9:236-43 - PubMed

MeSH terms

LinkOut - more resources